NIT
TNDM icon

NumerixS Investment Technologies’s Tandem Diabetes Care TNDM Stock Holding History

NumerixS Investment Technologies’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,700
Closed -$267K – 774
2020
Q2 		$267K Sell
2,700
-1,244
-32% -$99.3K 0.07% 303
2020
Q1 		$254K Sell
3,944
-28,765
-88% -$2.02M 0.13% 188
2019
Q4 		$1.95M Buy
32,709
+25,709
+367% +$1.59M 0.38% 43
2019
Q3 		$413K Sell
7,000
-6,381
-48% -$407K 0.11% 199
2019
Q2 		$863K Buy
13,381
+981
+8% +$63.3K 0.25% 88
2019
Q1 		$790K Buy
+12,400
New +$651K 0.11% 236

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

NumerixS Investment Technologies's TNDM Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Tandem Diabetes Care (TNDM) in Q3 2020, closing a stake of 2,700 shares — an estimated $267K sold.

NumerixS Investment Technologies first reported a position in TNDM in Q1 2019 and held it in 6 quarters. The position peaked at $1.95M in Q4 2019. 321 funds tracked by Wall St. Rank hold TNDM as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining Tandem Diabetes Care position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 2,700 Tandem Diabetes Care shares in Q3 2020, an estimated $267K.
  • NumerixS Investment Technologies first reported a position in Tandem Diabetes Care in Q1 2019 and held it in 6 quarters.
  • NumerixS Investment Technologies's Tandem Diabetes Care position peaked at $1.95M in Q4 2019.
  • 321 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.